Wyeth Consumer Health Q2 Sales Sluggish As Cough/Cold Products Recover
This article was originally published in The Tan Sheet
Executive Summary
Wyeth Consumer Healthcare sales increased 4.2 percent to $623.2 million in the second quarter of 2007 as the Madison, N.J.-based firm continues to grapple with the federal restriction placed on pseudoephedrine (PSE) products